FDA Adverse Event Death Summary report: N

ENDEAVOR SPRINT RX CORONARY STENT SYSTEM

MDR report key: 1964120 · Received January 12, 2011

Report

Report Number
2953200-2011-00068
Event Type
Death
Date Received
January 12, 2011
Date of Event
January 1, 2009
Report Date
December 13, 2010
Manufacturer
MEDTRONIC CARDIOVASCULAR GALWAY
Product Code
NIQ
PMA / PMN Number
P060033
Removal / Correction Number
NA
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
GM
Reporter Occupation
PHYSICIAN

Narratives

Additional Manufacturer Narrative · 1

(B)(4). EVAL, RESULTS: (DEATH).

Description of Event or Problem · 1

THE PT HAD ONE ENDEAVOR SPRINT RAPID EXCHANGE DRUG-ELUTING STENT IMPLANTED TO THE PROXIMAL LAD. PT WAS DISCHARGED TWO WEEKS POST INDEX PROCEDURE ON ASPIRIN AND CLOPIDOGREL. PT CARDIAC STATUS AT 30 DAY F/U WAS STABLE ANGINA. (REF. MFR 2953200-2011-00069). APPROX 6.5 WEEKS POST INDEX POST INDEX PROCEDURE REVASCULARIZATION (PTCA) OF THE PROXIMAL LCX WITH STENTING WAS PERFORMED. INDICATION FOR SURGERY WAS POSITIVE HISTORY OR RECURRENT ANGINA PECTORIS PRESUMABLY RELATED TO THE TARGET VESSEL. THE EVENT WAS CONSIDERED NOT LIFE THREATENING. ONE ENDEAVOR SPRINT RAPID EXCHANGE DRUG-ELUTING STENT WAS IMPLANTED TO THE PROXIMAL LCX. THIS WAS CLASSIFIED AS A NON-TARGET VESSEL. THE INVESTIGATOR INDICATED THAT THE REPORTED EVENT WAS NOT RELATED TO THE STUDY STENT/ PROCEDURE. APPROX 10.5 MONTHS POST INDEX PROCEDURE THE PT SUFFERED A NON SUDDEN CARDIAC DEATH. PT WAS HOSPITALIZED WITH DYSPNOEA AND WEAK CONDITION. INCREASING PLEURAL EFFUSION. WORSENING OF CONDITION REANIMATION AND EXITUS LETALIS. NO AUTOPSY REPORT AVAILABLE. THE INVESTIGATOR INDICATED THAT THE REPORTED EVENT WAS NOT RELATED TO THE STUDY STENT/ PROCEDURE. PT WAS TAKING ASPIRIN AND CLOPIDOGREL/TICLOPIDINE PRIOR TO THE REPORTED EVENT.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1 ENDEAVOR SPRINT RX CORONARY STENT SYSTEM NIQ MEDTRONIC CARDIOVASCULAR GALWAY NA 0000535564

Patients

Seq Age Sex Outcome Treatment
1 82 YR Death 24 HOURS BEFORE THE EVENT| CLOPIDOGREL/ TICLOPIDINE| ASPIRIN